S.1663

Therapeutic Fraud Prevention Act of 2025

Introduced·5/7/25
Introduced

S. 1663

Introduced in Senate · May 27, 2025

May 7, 2025

Mrs. Murray (for herself, Mr. Booker, Ms. Baldwin, Mr. Bennet, Mr. Blumenthal, Ms. Cantwell, Mr. Coons, Ms. Cortez Masto, Ms. Duckworth, Mr. Durbin, Mr. Fetterman, Mrs. Gillibrand, Ms. Hassan, Mr. Heinrich, Mr. Hickenlooper, Ms. Hirono, Mr. Kaine, Mr. Kelly, Mr. Kim, Mr. King, Ms. Klobuchar, Mr. Luján, Mr. Markey, Mr. Merkley, Mr. Murphy, Mr. Padilla, Mr. Reed, Ms. Rosen, Mr. Sanders, Mr. Schiff, Mrs. Shaheen, Ms. Slotkin, Ms. Smith, Mr. Van Hollen, Ms. Warren, Mr. Welch, Mr. Whitehouse, and Mr. Wyden) introduced the following bill; which was read twice and referred to the Committee on Commerce, Science, and Transportation

A BILL

To prohibit commercial sexual orientation conversion therapy, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Therapeutic Fraud Prevention Act of 2025”.